BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34350068)

  • 1. Multi-Compartment Spatially-Derived Radiomics From Optical Coherence Tomography Predict Anti-VEGF Treatment Durability in Macular Edema Secondary to Retinal Vascular Disease: Preliminary Findings.
    Sil Kar S; Sevgi DD; Dong V; Srivastava SK; Madabhushi A; Ehlers JP
    IEEE J Transl Eng Health Med; 2021; 9():1000113. PubMed ID: 34350068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Features of Vessels and Leakage Patterns Predict Extended Interval Aflibercept Dosing Using Ultra-Widefield Angiography in Retinal Vascular Disease: Findings From the PERMEATE Study.
    Moosavi A; Figueiredo N; Prasanna P; Srivastava SK; Sharma S; Madabhushi A; Ehlers JP
    IEEE Trans Biomed Eng; 2021 Jun; 68(6):1777-1786. PubMed ID: 32822291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics-based assessment of ultra-widefield leakage patterns and vessel network architecture in the PERMEATE study: insights into treatment durability.
    Prasanna P; Bobba V; Figueiredo N; Sevgi DD; Lu C; Braman N; Alilou M; Sharma S; Srivastava SK; Madabhushi A; Ehlers JP
    Br J Ophthalmol; 2021 Aug; 105(8):1155-1160. PubMed ID: 32816791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT-Derived Radiomic Features Predict Anti-VEGF Response and Durability in Neovascular Age-Related Macular Degeneration.
    Kar SS; Cetin H; Lunasco L; Le TK; Zahid R; Meng X; Srivastava SK; Madabhushi A; Ehlers JP
    Ophthalmol Sci; 2022 Dec; 2(4):100171. PubMed ID: 36531588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning and optical coherence tomography-derived radiomics analysis to predict persistent diabetic macular edema in patients undergoing anti-VEGF intravitreal therapy.
    Meng Z; Chen Y; Li H; Zhang Y; Yao X; Meng Y; Shi W; Liang Y; Hu Y; Liu D; Xie M; Yan B; Luo J
    J Transl Med; 2024 Apr; 22(1):358. PubMed ID: 38627718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning Can Predict Anti-VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema.
    Gallardo M; Munk MR; Kurmann T; De Zanet S; Mosinska A; Karagoz IK; Zinkernagel MS; Wolf S; Sznitman R
    Ophthalmol Retina; 2021 Jul; 5(7):604-624. PubMed ID: 33971352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
    Hwang HS; Chae JB; Kim JY; Kim DY
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5958-5967. PubMed ID: 29183041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of response to anti-vascular endothelial growth factor treatment in diabetic macular oedema using an optical coherence tomography-based machine learning method.
    Cao J; You K; Jin K; Lou L; Wang Y; Chen M; Pan X; Shao J; Su Z; Wu J; Ye J
    Acta Ophthalmol; 2021 Feb; 99(1):e19-e27. PubMed ID: 32573116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Texture-Based Radiomic SD-OCT Features Associated With Response to Anti-VEGF Therapy in a Phase III Neovascular AMD Clinical Trial.
    Sil Kar S; Cetin H; Srivastava SK; Madabhushi A; Ehlers JP
    Transl Vis Sci Technol; 2024 Jan; 13(1):29. PubMed ID: 38289610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous Cytokine Expression and Higher Order OCT Biomarkers: Assessment of the Anatomic-Biologic Bridge in the IMAGINE DME Study.
    Abraham JR; Wykoff CC; Arepalli S; Lunasco L; Yu HJ; Hu M; Reese J; Srivastava SK; Brown DM; Ehlers JP
    Am J Ophthalmol; 2021 Feb; 222():328-339. PubMed ID: 32896498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Residual Retinal Fluid Following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review.
    Patil NS; Mihalache A; Dhoot AS; Popovic MM; Muni RH; Kertes PJ
    Ophthalmic Surg Lasers Imaging Retina; 2023 Jan; 54(1):50-58. PubMed ID: 36626212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index.
    Ehlers JP; Uchida A; Hu M; Figueiredo N; Kaiser PK; Heier JS; Brown DM; Boyer DS; Do DV; Gibson A; Saroj N; Srivastava SK
    Ophthalmol Retina; 2019 Dec; 3(12):1056-1066. PubMed ID: 31473172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy.
    Eraslan S; Yıldırım Ö; Dursun Ö; Dinç E; Orekici Temel G
    Turk J Ophthalmol; 2020 Jun; 50(3):163-168. PubMed ID: 32631004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
    Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
    Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
    Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of aflibercept for the treatment of persistent macular oedema secondary to retinal vein occlusions in eyes not responsive to long-term treatment with bevacizumab or ranibizumab.
    Spooner K; Fraser-Bell S; Hong T; Chang A
    Clin Exp Ophthalmol; 2020 Jan; 48(1):53-60. PubMed ID: 31498950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal Fluid Volatility Associated With Interval Tolerance and Visual Outcomes in Diabetic Macular Edema in the VISTA Phase III Trial.
    Ehlers JP; Uchida A; Sevgi DD; Hu M; Reed K; Berliner A; Vitti R; Chu K; Srivastava SK
    Am J Ophthalmol; 2021 Apr; 224():217-227. PubMed ID: 33253664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intravitreal anti-vascular endothelial growth factor or steroid injection in diabetic macular edema according to fluid turbidity in optical coherence tomography.
    Lee K; Chung H; Park Y; Sohn J
    Korean J Ophthalmol; 2014 Aug; 28(4):298-305. PubMed ID: 25120338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Boiko EV; Maltsev DS
    Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.